6VDL

HCV NS3/4A protease A156T mutant in complex with glecaprevir

Summary for 6VDL

• Entry DOI: 10.2210/pdb6vdl/pdb
• Descriptor: Non-structural protein 4A, Serine protease NS3, ZINC ION, (3aR,7S,10S,12R,21E,24aR)-7-tert-butyl-N-[(1R,2R)-2-(difluoromethyl)-1-{[(1-methylcyclopropyl)sulfonyl]carbamoyl}cyclop ropyl]-20,20-difluoro-5,8-dioxo-2,3,3a,5,6,7,8,11,12,20,23,24a-dodecahydro-1H,10H-9,12-methanocyclopenta[18,19][1,10,17, 3,6]trioxadiazacyclononadecino[11,12-b]quinoxaline-10-carboxamide, ... (6 entities in total)
• Functional Keywords: hcv protease, ns34a protease, glecaprevir, viral protein
• Biological source: Hepatitis C virus genotype 1a (isolate 1) (HCV); More
• Total number of polymer chains: 1
• Total formula weight: 22830.01

Authors

Timm, J.,Schiffer, C.A. (deposition date: 2019-12-27, release date: 2020-12-30, Last modification date: 2023-10-11)

• Primary citation: Timm, J.,Zephyr, J.,Hou, S.,Kurt Yilmaz, N.,Schiffer, C.A.; RAS at position 156 of HCV NS3/4A protease abolish inhibition by current HCV drugs; To Be Published,

Experimental method

X-RAY DIFFRACTION (1.95 Å)